Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Cordon-Cardo

Showing results (1-10 of 351) with videos related to

Pageof 36
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2004
p53 and RB: simple interesting correlates or tumor markers of critical predictive nature?Carlos Cordon-Cardo
Scandinavian Journal of Urology and Nephrology. Supplementum|December 5, 2008
Molecular alterations associated with bladder cancer initiation and progressionCarlos Cordon-Cardo
Molecular Cancer Research : MCR|February 6, 2004
MDM2 and prognosisKenan Onel, Carlos Cordon-Cardo
Oncogene|June 6, 2003
Oncogenes in melanomaDavid Polsky, Carlos Cordon-Cardo
Cancer Cell|February 19, 2021
The human leukocyte antigen as a candidate tumor suppressorElisabet Pujadas, Carlos Cordon-Cardo
Current Opinion in Urology|March 13, 2013
Predicting high-risk disease using tissue biomarkersMichael J Donovan, Carlos Cordon-Cardo
Molecular Diagnosis & Therapy|December 22, 2016
Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive OutcomesMichael J Donovan, Carlos Cordon-Cardo
Current Opinion in Urology|March 15, 2014
Genomic analysis in active surveillance: predicting high-risk disease using tissue biomarkersMichael J Donovan, Carlos Cordon-Cardo
Expert Review of Molecular Diagnostics|October 21, 2014
Overcoming tumor heterogeneity in the molecular diagnosis of urological cancersMichael J Donovan, Carlos Cordon-Cardo
Nature Clinical Practice. Urology|January 11, 2007
Technology insight: will systems pathology replace the pathologist?Olivier Saidi, Carlos Cordon-Cardo, Jose Costa
Pageof 36

Showing results (1-10 of 351) with videos related to

Sort By:
Pageof 36
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2004
p53 and RB: simple interesting correlates or tumor markers of critical predictive nature?Carlos Cordon-Cardo
Scandinavian Journal of Urology and Nephrology. Supplementum|December 5, 2008
Molecular alterations associated with bladder cancer initiation and progressionCarlos Cordon-Cardo
Molecular Cancer Research : MCR|February 6, 2004
MDM2 and prognosisKenan Onel, Carlos Cordon-Cardo
Oncogene|June 6, 2003
Oncogenes in melanomaDavid Polsky, Carlos Cordon-Cardo
Cancer Cell|February 19, 2021
The human leukocyte antigen as a candidate tumor suppressorElisabet Pujadas, Carlos Cordon-Cardo
Current Opinion in Urology|March 13, 2013
Predicting high-risk disease using tissue biomarkersMichael J Donovan, Carlos Cordon-Cardo
Molecular Diagnosis & Therapy|December 22, 2016
Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive OutcomesMichael J Donovan, Carlos Cordon-Cardo
Current Opinion in Urology|March 15, 2014
Genomic analysis in active surveillance: predicting high-risk disease using tissue biomarkersMichael J Donovan, Carlos Cordon-Cardo
Expert Review of Molecular Diagnostics|October 21, 2014
Overcoming tumor heterogeneity in the molecular diagnosis of urological cancersMichael J Donovan, Carlos Cordon-Cardo
Nature Clinical Practice. Urology|January 11, 2007
Technology insight: will systems pathology replace the pathologist?Olivier Saidi, Carlos Cordon-Cardo, Jose Costa
Pageof 36